These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 36646283)

  • 1. Characterization of Recombinantly-Expressed Hydrolytic Enzymes from Chinese Hamster Ovary Cells: Identification of Host Cell Proteins that Degrade Polysorbate.
    Kovner D; Yuk IH; Shen A; Li H; Graf T; Gupta S; Liu W; Tomlinson A
    J Pharm Sci; 2023 May; 112(5):1351-1363. PubMed ID: 36646283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and Characterization of Polysorbate-Degrading Enzymes in a Monoclonal Antibody Formulation.
    Graf T; Tomlinson A; Yuk IH; Kufer R; Spensberger B; Falkenstein R; Shen A; Li H; Duan D; Liu W; Wohlrab S; Edelmann F; Leiss M
    J Pharm Sci; 2021 Nov; 110(11):3558-3567. PubMed ID: 34224732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Illuminating a biologics development challenge: systematic characterization of CHO cell-derived hydrolases identified in monoclonal antibody formulations.
    Maier M; Weiß L; Zeh N; Schmieder-Todtenhaupt V; Dehghani A; Felix MN; Heinzelmann D; Lindner B; Schmidt M; Studts J; Schulz P; Reisinger B; Otte K; Franzreb M; Lakatos D; Fischer S
    MAbs; 2024; 16(1):2375798. PubMed ID: 38984665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and characterization of co-purifying CHO host cell proteins in monoclonal antibody purification process.
    Liu X; Chen Y; Zhao Y; Liu-Compton V; Chen W; Payne G; Lazar AC
    J Pharm Biomed Anal; 2019 Sep; 174():500-508. PubMed ID: 31234041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polysorbates 20 and 80 Degradation by Group XV Lysosomal Phospholipase A2 Isomer X1 in Monoclonal Antibody Formulations.
    Hall T; Sandefur SL; Frye CC; Tuley TL; Huang L
    J Pharm Sci; 2016 May; 105(5):1633-1642. PubMed ID: 27056628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Highly Sensitive LC-MS/MS Method for Targeted Quantitation of Lipase Host Cell Proteins in Biotherapeutics.
    Chen Y; Xu CF; Stanley B; Evangelist G; Brinkmann A; Liu S; McCarthy S; Xiong L; Jones E; Sosic Z; Yeung B
    J Pharm Sci; 2021 Dec; 110(12):3811-3818. PubMed ID: 34461112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Knockout of a difficult-to-remove CHO host cell protein, lipoprotein lipase, for improved polysorbate stability in monoclonal antibody formulations.
    Chiu J; Valente KN; Levy NE; Min L; Lenhoff AM; Lee KH
    Biotechnol Bioeng; 2017 May; 114(5):1006-1015. PubMed ID: 27943242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization and stability study of polysorbate 20 in therapeutic monoclonal antibody formulation by multidimensional ultrahigh-performance liquid chromatography-charged aerosol detection-mass spectrometry.
    Li Y; Hewitt D; Lentz YK; Ji JA; Zhang TY; Zhang K
    Anal Chem; 2014 May; 86(10):5150-7. PubMed ID: 24749737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessing the polysorbate degradation fingerprints and kinetics of lipases - how the activity of polysorbate degrading hydrolases is influenced by the assay and assay conditions.
    Glücklich N; Carle S; Buske J; Mäder K; Garidel P
    Eur J Pharm Sci; 2021 Nov; 166():105980. PubMed ID: 34419573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of Acyl-Protein Thioesterase-1 as a Polysorbate-Degrading Host Cell Protein in a Monoclonal Antibody Formulation Using Activity-Based Protein Profiling.
    Šprager E; Möller J; Lin Y; Reisinger V; Bratkovič T; Lunder M; Vašl J; Krajnc A
    J Pharm Sci; 2024 May; ():. PubMed ID: 38772451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and Quantification of a Problematic Host Cell Protein to Support Therapeutic Protein Development.
    E SY; Hu Y; Molden R; Qiu H; Li N
    J Pharm Sci; 2023 Mar; 112(3):673-679. PubMed ID: 36220394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-Throughput, Fluorescence-Based Esterase Activity Assay for Assessing Polysorbate Degradation Risk during Biopharmaceutical Development.
    Bhargava AC; Mains K; Siu A; Gu J; Zarzar J; Yi L; Yuk IH
    Pharm Res; 2021 Mar; 38(3):397-413. PubMed ID: 33655394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Profiling Active Enzymes for Polysorbate Degradation in Biotherapeutics by Activity-Based Protein Profiling.
    Li X; Chandra D; Letarte S; Adam GC; Welch J; Yang RS; Rivera S; Bodea S; Dow A; Chi A; Strulson CA; Richardson DD
    Anal Chem; 2021 Jun; 93(23):8161-8169. PubMed ID: 34032423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How enzymatic hydrolysis of polysorbate 20 influences colloidal protein stability.
    Glücklich N; Carle S; Diederichs T; Buske J; Mäder K; Garidel P
    Eur J Pharm Sci; 2023 Dec; 191():106597. PubMed ID: 37770006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Controlled polysorbate 20 hydrolysis - A new approach to assess the impact of polysorbate 20 degradation on biopharmaceutical product quality in shortened time.
    Graf T; Abstiens K; Wedekind F; Elger C; Haindl M; Wurth C; Leiss M
    Eur J Pharm Biopharm; 2020 Jul; 152():318-326. PubMed ID: 32445968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insights into ultra-low affinity lipase-antibody noncovalent complex binding mechanisms.
    Hecht ES; Mehta S; Wecksler AT; Aguilar B; Swanson N; Phung W; Dubey Kelsoe A; Benner WH; Tesar D; Kelley RF; Sandoval W; Sreedhara A
    MAbs; 2022; 14(1):2135183. PubMed ID: 36284469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Putative Phospholipase B-Like 2 is Not Responsible for Polysorbate Degradation in Monoclonal Antibody Drug Products.
    Zhang S; Xiao H; Goren M; Burakov D; Chen G; Li N; Tustian A; Adams B; Mattila J; Bak H
    J Pharm Sci; 2020 Sep; 109(9):2710-2718. PubMed ID: 32534029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multi-lipase gene knockdown in Chinese hamster ovary cells using artificial microRNAs to reduce host cell protein mediated polysorbate degradation.
    Weiß L; Schmieder-Todtenhaupt V; Haemmerling F; Lakatos D; Schulz P; Fischer S
    Biotechnol Bioeng; 2024 Jan; 121(1):329-340. PubMed ID: 37743807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A fast and sensitive high-throughput assay to assess polysorbate-degrading hydrolytic activity in biopharmaceuticals.
    Gupta SK; Graf T; Edelmann FT; Seelmann H; Reintinger M; Hillringhaus L; Bergmann F; Wiedmann M; Falkenstein R; Wegele H; Yuk IH; Leiss M
    Eur J Pharm Biopharm; 2023 Jun; 187():120-129. PubMed ID: 37116764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of Polysorbate Ester Fractions and Implications in Protein Drug Product Stability.
    Tomlinson A; Zarraga IE; Demeule B
    Mol Pharm; 2020 Jul; 17(7):2345-2353. PubMed ID: 32442382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.